Middle East & Africa Enteral Nutrition Market Forecast to 2030 - Regional Analysis - by Product Type, Application, Age Group, and Distribution Channel

The Middle East & Africa enteral nutrition market was valued at US$ 395.69 million in 2022 and is expected to reach US$ 569.24 million by 2030; it is estimated to grow at a CAGR of 4.7% from 2022 to 2030.

Specific Formulations and Plant-Based Nutrition Products Fuels the Middle East & Africa Enteral Nutrition Market

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Functionality and specific formulations of enteral products do not interfere with the existing treatments of patients. The macro-nutrient and micronutrient formulations of enteral nutrition and their applications vary based on the disease under consideration. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction.

Standardized enteral nutrition products contain fixed constituents and are designed to meet an average patient's nutritional requirements, considering different requirements in different age groups. For example, Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders.

Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are becoming increasingly intolerant of artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. Abbott adds that consumers and patients relying on tube feeding are no exception to this trend. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults.

Therefore, functional, patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral nutrition market.

Middle East & Africa Enteral Nutrition Market Overview

The Middle East & Africa enteral nutrition market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The enteral nutrition market is expected to grow due to the increasing cases of cancer and stroke, as well as growing malnutrition among adults and premature babies across the region. Moreover, the growing government initiatives in the region propels the market growth.

According to a mid-2020 report from the General Authority for Statistics, ~25,000 babies are born prematurely in the country yearly. The premature babies are placed in incubators for 30 to 60 days. This can cost government hospitals or insurance companies ~US$ 16,000 (SAR 60,000) for individual treatment and specialized care. If babies are required to be kept in incubation for longer periods, it can cost ~US$ 26,667 (SAR 100,000). In such a scenario, nutritional support is crucial to attain a similar growth rate compared to babies of the same age, and it can be provided through enteral ways. Tube feeding is the preferred and safest route in enteral nutrition, as premature infants cannot coordinate sucking, swallowing, and breathing.

Middle East & Africa Enteral Nutrition Market Segmentation

The Middle East & Africa enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.

Based on product type, the Middle East & Africa enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger Middle East & Africa enteral nutrition market share in 2022.

In terms of application, the Middle East & Africa enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest Middle East & Africa enteral nutrition market share in 2022.

Based on age group, the Middle East & Africa enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger Middle East & Africa enteral nutrition market share in 2022.

By distribution channel, the Middle East & Africa enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest Middle East & Africa enteral nutrition market share in 2022.

Based on country, the Middle East & Africa enteral nutrition market is categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa enteral nutrition market in 2022.

Abbott Laboratories, Arla Foods amba, B Braun SE, Danone SA, Dr Schar AG, Fonterra Co-Operative Group Ltd, Fresenius SE & Co KGaA, Nestle SA, Perrigo Co Plc, Reckitt Benckiser Group Plc, and Royal FrieslandCampina NV are some of the leading companies operating in the Middle East & Africa enteral nutrition market.